Pharma Tech Outlook Names NMS Group a Top Drug Discovery and Development Solution Provider in Europe 2021

by nms-sync | Sep 29, 2021 | News

NMS Group is proud to be named by Pharma Tech Outlook as Top drug discovery and development solution providers in Europe for 2021 and featured in the cover of this special issue. The annual list showcases companies that are providing cutting-edge drug...

Protected: Accelera and BiomimX: Commercial agreement

by nms-sync | Jun 30, 2021 | News

Password Protected

To view this protected post, enter the password below:

Accelera and CROSS: an integrated solution for Pre-clinical to Clinical transition

by nms-sync | May 17, 2021 | News

Nerviano, 17 May 2021 The relationship between Accelera and CROss Alliance® started a decade ago and since then we have renewed our collaboration during the years. Our specializations, preclinical and early phase clinical development respectively, our shared...

Pharma Tech Outlook Names NMS Group a Top Drug Discovery and Development Solution Provider in Europe 2021

Protected: Accelera and BiomimX: Commercial agreement

Password Protected

Accelera and CROSS: an integrated solution for Pre-clinical to Clinical transition

Recent Posts

Recent Comments